ResearcherJohns Hopkins UniversityActive in the last 2 years
Mengni He
Matched on OpenAlex author ID A5038618994. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 16
2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: 1 paper · 2025: 1 paper
Papers 3
- Chemotherapy in synergy with innate immune agonists enhances T cell priming for checkpoint inhibitor treatment in pancreatic cancer. Co-author DOI 10.1186/s40364-024-00721-7↗
- Overcome the challenge for intratumoral injection of STING agonist for pancreatic cancer by systemic administration. Co-author DOI 10.1186/s13045-024-01576-z↗
- Preclinical mouse models for immunotherapeutic and non-immunotherapeutic drug development for pancreatic ductal adenocarcinoma. Co-author DOI 10.21037/apc.2020.03.03↗
Closest collaborators
The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Lei Zheng · 3 shared papers, 2020–2025 · strength 0.52
- Paper Chemotherapy in synergy with innate immune agonists enhances T cell priming for checkpoint inhibitor treatment in pancr… DOI 10.1186/s40364-024-00721-7↗
- Paper Overcome the challenge for intratumoral injection of STING agonist for pancreatic cancer by systemic administration. DOI 10.1186/s13045-024-01576-z↗
- Paper Preclinical mouse models for immunotherapeutic and non-immunotherapeutic drug development for pancreatic ductal adenoca… DOI 10.21037/apc.2020.03.03↗
- Brian T. Herbst · 2 shared papers, 2024–2025 · strength 0.37
- Paper Chemotherapy in synergy with innate immune agonists enhances T cell priming for checkpoint inhibitor treatment in pancr… DOI 10.1186/s40364-024-00721-7↗
- Paper Overcome the challenge for intratumoral injection of STING agonist for pancreatic cancer by systemic administration. DOI 10.1186/s13045-024-01576-z↗
- Nan Niu · 2 shared papers, 2024–2025 · strength 0.37
- Paper Chemotherapy in synergy with innate immune agonists enhances T cell priming for checkpoint inhibitor treatment in pancr… DOI 10.1186/s40364-024-00721-7↗
- Paper Overcome the challenge for intratumoral injection of STING agonist for pancreatic cancer by systemic administration. DOI 10.1186/s13045-024-01576-z↗
- Keyu Li · 2 shared papers, 2024–2025 · strength 0.37
- Paper Chemotherapy in synergy with innate immune agonists enhances T cell priming for checkpoint inhibitor treatment in pancr… DOI 10.1186/s40364-024-00721-7↗
- Paper Overcome the challenge for intratumoral injection of STING agonist for pancreatic cancer by systemic administration. DOI 10.1186/s13045-024-01576-z↗
- Sami Shoucair · 1 shared paper, 2025 · strength 0.21
- Jun-Ke Wang · 1 shared paper, 2025 · strength 0.21
- Yiping Mou · 1 shared paper, 2025 · strength 0.21
- Noelle R. Jurcak · 1 shared paper, 2024 · strength 0.16
- Xu-Bao Liu · 1 shared paper, 2024 · strength 0.16
- Junke Wang · 1 shared paper, 2024 · strength 0.16
- Noah S Rozich · 1 shared paper, 2024 · strength 0.16
- Chunhui Yuan · 1 shared paper, 2024 · strength 0.16
- Arsen Osipov · 1 shared paper, 2024 · strength 0.16
- Alex B. Blair · 1 shared paper, 2024 · strength 0.16
- Stephen T. Muth · 1 shared paper, 2020 · strength 0.15
- Adrian Gerard Murphy · 1 shared paper, 2020 · strength 0.15
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.